Melinda J. Gooderham, MSc, MD, FRCPC

SKiN Centre for Dermatology

775 Monaghan Road
Peterborough, Ontario, Canada
K9J 5K2
705-874-1533

 

Specialty: Dermatology

Dr. Melinda Gooderham, Dermatologist, Specialist in Psoriasis

 

Research Interests: Acne, Actinic Keratoses, Alopecia, Atopic Dermatitis, Basal Cell Carcinoma, Onycomycosis, Psoriasis, Psoriatic Arthritis, Rosacea, Seborrheic Dermatitis, Vaccines

 

Dr. Gooderham is a board certified Dermatologist and Medical Director at the SKiN Centre for Dermatology in Peterborough, Ontario. She is an Assistant Professor at Queen's University and also works as a Consultant Physician at the Peterborough Regional Health Centre.

Dr. Gooderham is responsible for opening the first Comprehensive Dermatology Centre in the Kawartha Region, which includes a state-of-the-art Dermatology Clinical Research Centre, Phototherapy and Psoriasis Treatment Centre, Patch Test Clinic, and Laser Clinic. Dr. Gooderham and her clinical research staff are dedicated to advancing clinical research in dermatology, including the development of new treatments for psoriasis.

Dr. Gooderham belongs to a number of professional societies including the Canadian Dermatology Association, American Academy of Dermatology and the European Academy of Dermatology and Venereology. She is actively involved in teaching medical students, nurse practitioners and physicians both with didactic lectures and hands-on clinical teaching.

 

Click to view Dr. Melinda Gooderham's Publications

Pickard AS, Gooderham M, Hartz DS, Nicolay C. EQ-5D health utilities: Exploring ways to improve upon responsiveness in psoriasis. J Med Econ 2016 Jul 29; 1-31. [Epub ahead of print]. PMID: 27471948 / doi: 10.1080/13696998.2016.1219359

Bissonnette R, Papp KA, Poulin Y, Gooderham M, Raman M, Mallbris L, Wang C, Purohit V, Mamolo C, Papacharalambous J, Ports WC. Topical tofacitinib for atopic dermatitis: A Phase 2a randomised trial. Br J Dermatol 2016 Jul 16 [Epub ahead of print]. PMID: 27423107 / doi: 10.1111/bjd.14871

Gooderham M, Gavino-Velasco J, Clifford C, MacPherson A, Krasnoshtein F, Papp K. A review of psoriasis, therapies, and suicide. J Cutan Med Surg 2016 Jul; 20(4): 293-303. Epub 2016 May 5. PMID: 27207348 / doi: 10.1177/1203475416648323

Menter A, Papp KA, Gooderham M, Pariser DM, Augustin M, Kerdel FA, Fakharzadeh S, Goyal K, Calabro S, Langholff W, Chavers S, Naessens D, Sermon J, Krueger GG. Drug survival of biologic therapy in a large, disease-based registry of patients with psoriasis: results from the Psoriasis Longitudinal Assessment and Registry (PSOLAR). J Eur Acad Dermatol Venereol 2016 Jul; 30(7): 1148-58. Epub 2016 Mar 30. PMID: 27027388 / doi: 10.1111/jdv.13611

Blakely K, Gooderham M, Papp K. Dupilumab, a monoclonal antibody for atopic dermatitis: a review of current literature. Skin Therapy Letter 2016 Mar-Apr; 21(2): 1-5.

Blakely K, Gooderham M. Management of scalp psoriasis: current perspectives. Psoriasis: Targets and Therapy 2016 Mar 29; 6: 33-40.

Gooderham MJ, Poulin-Costello M, Shelton J, Bayan N, Papp KA. Predictors of topical use in psoriasis patients in the REFINE study. J Cutan Med Surg 2016 Mar; 20(2): 106-12. Epub 2015 Sep 1. PMID: 26330052 / doi: 10.1177/1203475415604322

Rich P, Gooderham M, Bachelez H, Goncalves J, Day RM, Chen R, Crowley J. Apremilast, an oral phosphodiesterase 4 inhibitor, in patients with difficult-to-treat nail and scalp psoriasis: Results of 2 phase III randomized, controlled trials (ESTEEM 1 and ESTEEM 2). J Am Acad Dermatol 2016 Jan; 74(1): 134-42. PMID: 26549249 / doi: 10.1016/j.jaad.2015.09.001

Paul C, Cather J, Gooderham M, Poulin Y, Mrowietz U, Ferrandiz C, Crowley J, Hu C, Stevens RM, Shah K, Day RM, Girolomoni G, Gottlieb AB. Efficacy and safety of apremilast, an oral phosphodiesterase 4 inhibitor, in patients with moderate-to-severe plaque psoriasis over 52 weeks: a phase III, randomized controlled trial (ESTEEM 2). Br J Dermatol. 2015 Dec; 173(6): 1387-99. Epub 2015 Nov 7. PMID: 26357944 / doi: 10.1111/bjd.14164

Gooderham M, Papp K. The psychosocial impact of hidradenitis suppurativa. J Am Acad Dermatol 2015 Nov; 73(5 Suppl 1): S19-22. PMID: 26470609 / doi: 10.1016/j.jaad.2015.07.054

Gooderham M, Papp K. Selective phosphodiesterase inhibitors for psoriasis: focus on apremilast. BioDrugs 2015 Oct; 29(5): 327-39. PMID: 26481941

Gooderham M, Papp K. Apremilast in the treatment of psoriasis and psoriatic arthritis. Skin Therapy Lett 2015 Sep-Oct; 20(5): 1-6. PMID: 26382906

Hartleib MC, Gooderham M. Top ten things rheumatologists should (and might not) know about inflammation and CV disease. CRAJ 2015 Fall; 25(3).

Ham K, Posso-De Los Rios CJ, Gooderham M. Methylisothiazolinone testing at 2000 ppm: a prevalent sensitizer for allergic contact dermatitis. Dermatitis 2015 Jul-Aug; 26(4): 166-9. PMID: 26172485 / doi: 10.1097/DER.0000000000000121

Gooderham M, Posso-De Los Rios CJ, Rubio-Gomez GA, Papp K. Interleukin-17 (IL-17) inhibitors in the treatment of plaque psoriasis: a review. Skin Therapy Lett 2015 Jan-Feb; 20(1): 1-5. PMID: 25807214

Gooderham M, Debarre JM, Keddy-Grant J, Xu Z, Kurvits M, Goodfield M. Safety and efficacy of calcipotriol plus betamethasone dipropionate gel in the treatment of scalp psoriasis in adolescents 12-17 years of age. Br J Dermatol 2014 Dec; 171(6): 1470-7. Epub 2014 Oct 22. PMID: 24980277 / doi: 10.1111/bjd.13235

Tan J, Humphrey S, Vender R, Barankin B, Gooderham M, Kerrouche N, Audibert F, Lynde C; POWER study group. A treatment for severe nodular acne: a randomized investigator-blinded, controlled, noninferiority trial comparing fixed-dose adapalene/benzoyl peroxide plus doxycycline vs. oral isotretinoin. Br J Dermatol 2014 Dec; 171(6): 1508-16. Epub 2014 Oct 28. PMID: 24934963 / doi: 10.1111/bjd.13191

Ham K, Maini P, Gooderham MJ. Real-world experience with alitretinoin in a community dermatology practice setting in patients with chronic hand dermatitis. J Cutan Med Surg 2014 Sep-Oct; 18(5): 332-6. PMID: 25186994

Gooderham M. Small molecules: an overview of emerging therapeutic options in the treatment of psoriasis. Skin Therapy Lett 2013 Dec; 18(7): 1-4. PMID: 24305752

Fallen RS, Gooderham M. Rosacea: Update on management and emerging therapies. Skin Therapy Lett 2012 Nov-Dec; 17(10): 1-4. PMID: 23223767

Fallen RS, Gooderham M. Ingenol mebutate: An introduction. Skin Therapy Lett 2012 Feb; 17(2): 1-3. PMID: 22358305

Katipunan K, Gooderham M. Topical management of psoriasis and the role of vitamin D3 analogues. Skin Therapy Letter – Family Practice Edition 2011 Sep; 7(4).

Fallen RS, Gooderham M. Bedbugs: An update on recognition and management. Skin Therapy Lett 2011 Jun; 16(6): 5-7. PMID: 21833462

Davidson M, Gooderham M. Review of management options for genital herpes infections. Skin Therapy Letter – Family Practice Edition 2011 Feb; 7(1).

Gooderham M. A review of therapeutic options for genital warts. Skin Therapy Letter – Family Practice Edition 2009 Jun; 5(2): 1-4.

Gooderham M. A review of therapeutic options for genital warts. Skin Therapy Letter – Pharmacist Edition 2009 May-Jun; 4(1): 4-7.

Gooderham M. Rosacea and its topical management. Skin Therapy Lett 2009 Feb; 14(2): 1-3. PMID: 19330270

Gooderham M, Solish N. Use of hyaluronic acid for soft tissue augmentation of HIV-associated facial lipodystrophy. Dermatol Surg 2005 Jan; 31(1): 104-108. PMID: 15720106 

Gooderham MJ, Solish N. Diminished buccal fat. J Am Acad Dermatol 2004; 50(5): 804.

Gooderham MJ, DeKoven J. Crusted erosions on the back and intertriginous areas. J Am Acad Dermatol 2003; 48(5): 801-802.

Gooderham MJ, Shaw JC. Pruritic eruption in an elderly man. J Am Acad Dermatol 2003; 48(5): 802-803.

Gooderham MJ. Traumatic injury by a cat. J Am Acad Dermatol 2002; 47(5): 803-804.

Gooderham MJ. Newborn with fusion of the eyelids. J Am Acad Dermatol 2002; 47(5): 804.

Gooderham MJ, Bolli P, Fernandez PG. Concomitant digoxin toxicity and warfarin interaction in a patient receiving clarithromycin.  Ann Pharmacother 1999 Jul-Aug; 33(7-8): 796-799. PMID: 10466907

Gooderham MJ, Guenther L. Sun and the skin: evaluation of a sun awareness program for elementary school students. J Cutan Med Surg 1999 Jul; 3(5): 230-235. PMID: 10381945

Gooderham MJ, Guenther L. Impact of a sun awareness curriculum on medical students’ knowledge, attitudes, and behaviour. J Cutan Med Surg 1999 Apr; 3(4): 182-187. PMID: 10366391

Gooderham MJ, Adlercreutz H, Ojala ST, Wähälä K, Holub BJ. A soy protein isolate rich in genistein and daidzein and its effects on plasma isoflavone concentrations, platelet aggregation, blood lipids and fatty acid composition of plasma phospholipid in normal men. J Nutr 1996 Aug; 126(8): 2000-2006. PMID: 8759372

Copyright 2014 Probity Medical Research Inc. All Rights Reserved.

Login